Navigation Links
Final Vectibix Positive Pivotal Phase 3 Trial Results In Metastatic,Colorectal Cancer Patients Published

the world in the fight against cancer, kidney disease, rheumatoid arthritis, and other serious illnesses. With a deep and broad pipeline of potential new medicines, Amgen remains committed to advancing science to dramatically improve people's lives. To learn more about our pioneering science and our vital medicines, visit www.amgen.com.

Forward-Looking Statement

This news release contains forward-looking statements that involve significant risks and uncertainties, including those discussed below and others that can be found in Amgen's Form 10-K for the year ended December 31, 2005, and in Amgen's periodic reports on Form 10-Q and Form 8-K. Amgen is providing this information as of the date of this news release and does not undertake any obligation to update any forward-looking statements contained in this document as a result of new information, future events or otherwise.

No forward-looking statement can be guaranteed and actual results may differ materially from those Amgen projects. In addition, sales of Amgen's products are affected by the availability of reimbursement and the reimbursement policies imposed by third party payors, including governments, private insurance plans and managed care providers, and may be affected by domestic and international trends toward managed care and healthcare cost containment as well as possible U.S. legislation affecting pharmaceutical pricing and reimbursement. Government regulations and reimbursement policies may affect the development, usage and pricing of Amgen's products. In addition, Amgen competes with other companies with respect to some of Amgen's marketed products as well as for the discovery and development of new products. Amgen believes that some of the newer products, product candidates or new indications for existing products, may face competition when and as they are approved and marketed. Amgen products may compete against products that have lower prices, established reimbursement, superi
'"/>




Page: 1 2 3 4 5 6

Related medicine technology :

1. Human Genome Sciences Announces Positive Final Results Of Phase 2b Trial of Albuferon
2. Positive Final Data from HyCAMP Phase II Trial in Metastatic Colorectal
3. Intarcia Therapeutics Announces Presentation of Final Results From a Phase 2 Combination Study for the Treatment of Hepatitis C at the Digestive Disease Week Conference
4. Intarcia Therapeutics Announces Final Results From a Phase 2 Study of Injectable Omega Interferon plus Ribavirin for the Treatment of Hepatitis C Genotype-1
5. Cell Genesys Provides Final Median Survival Data From Second Phase 2 Trial of GVAX Immunotherapy for Prostate Cancer
6. Baxter Announces Final Phase I/II Data and Initiation of Phase III Clinical Trial for Candidate Pandemic H5N1 Influenza Vaccine
7. Neose Announces Presentation of Positive Preclinical Data on GlycoPEGylated Factor VIIa at the XXI Congress of the International Society on Thrombosis and Haemostasis
8. Positive Aggrastat Results Featured in the Journal of the American College of Cardiology
9. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
10. Protox Announces Positive Clinical Data from Prostate Cancer Study
11. AM-Pharma Announces Positive Results of Phase IIa Clinical Trial with Alkaline Phosphatase For Ulcerative Colitis
Post Your Comments:
(Date:9/12/2014)... --  Quest Diagnostics (NYSE: DGX ), ... celebrates a decade on the North America Dow Jones ... World DJSI. The Dow Jones Sustainability ... economic, environmental and social criteria. To be included or ... sustainability initiatives. "A sustainable business is a ...
(Date:9/12/2014)... 12, 2014  Rock Creek Pharmaceuticals, Inc., (NASDAQ: ... focused on chronic inflammatory disease and neurologic disorders, ... from the U.S. Food and Drug Administration (FDA) ... (NDIN) for the formulations of Anatabloc® and CigRx® submitted ... indicated that the FDA considers anatabine citrate, a principal ...
(Date:9/11/2014)... Fla. , Sept. 11, 2014 ... cancer-treatment research and development firm, has discovered substances ... sediment samples that were recovered from the ocean ... and Recovery Limited Partnership. Logo - ... exciting as the discovery of Gold Rush-era treasure ...
Breaking Medicine Technology:Quest Diagnostics Marks 10 Years on the Dow Jones Sustainability Index 2Rock Creek Pharmaceuticals Receives New Dietary Ingredient Notification (NDIN) Response 2Rock Creek Pharmaceuticals Receives New Dietary Ingredient Notification (NDIN) Response 3Odyssey Marine Exploration and Morphogenesis discover biotech 'treasures' in the deep 2Odyssey Marine Exploration and Morphogenesis discover biotech 'treasures' in the deep 3
(Date:9/15/2014)... September 15, 2014 Stem cells are ... and can divide (through mitosis) to produce more stem ... of cardiovascular diseases, leukemia (a kind of hematological system ... kidney and other parenchymal organs, etc. , Currently, cord ... amid stem cell upstream sectors and even the whole ...
(Date:9/15/2014)... In addition to hosting, Stone Chiropractic ... Chair massages will be offered by Katherine Smith LLMT, ... homemade jams and muffins. Elaine Bauman from Beauty ... teach about doTERRA Essential Oils while Amira Watters will ... from face-painting to a coloring table and more. ...
(Date:9/15/2014)... 15, 2014 Ticketability.com can offer online customers ... Toyota Center, and Smoothie King Center. Fans are happy to ... first headlining tour in a period of three years. , ... 2014 concerts at Ticketability.com. , Colorado concertgoers who reside in ... 1st Bank Center. Texas fans have two chances to see ...
(Date:9/15/2014)... 2014 Recently, Top 10 Best ... compared many web hosting companies and announced that ... best suppliers for webmasters from all over the ... hosting plan. The company’s approach to hosting is ... accessible and powerful enough for anyone to use. ...
(Date:9/15/2014)... With a simple swab of the cheek, ... insight to help personalize the treatment for patients with vascular ... ideal approach to medicine is preventive care. But, it can ... will respond to specific drugs. A simple cheek swab test ... the physician to tailor medical therapy and optimize outcomes. , ...
Breaking Medicine News(10 mins):Health News:Global and China Stem Cell Industry Report 2014-2017 Now Available at ChinaMarketResearchReports.com 2Health News:Global and China Stem Cell Industry Report 2014-2017 Now Available at ChinaMarketResearchReports.com 3Health News:Global and China Stem Cell Industry Report 2014-2017 Now Available at ChinaMarketResearchReports.com 4Health News:Stone Chiropractic Brings Local Businesses Together for a Community Fall Festival 2Health News:Stone Chiropractic Brings Local Businesses Together for a Community Fall Festival 3Health News:Ticketability.com Unleashes 2014 Usher Tickets for 1st Bank Center, American Airlines Center, Toyota Center, and Smoothie King Center Concerts 2Health News:Top 10 Best SEO Hosting: Justhost And Bluehost Are The Best Suppliers For Webmasters 2Health News:Center for Vascular Medicine Offers Genetic Testing For Personalized Vascular Care 2
... that combination asthma therapy, SYMBICORT leads to significant ... greater patient-reported satisfaction with asthma treatment, versus ... ,SYMBICORT is a recently approved, combination therapy ... in patients 12 years of age and older. ...
... imaging technique - magnetic resonance elastography (MRE) - is an ... ,The studies were conducted by a team of ... ,As part of one study, researchers conducted MRE examinations of ... ,The researchers found that MRE accurately detects ...
... bumps and bruises to contribute to a hostile ... harms another individual, through the manipulation of ... significant a concern for adolescent psychosocial development and ... Montclair State University and her colleagues from the ...
... joined forces with Canadian biotech company GangaGen Life Sciences ... food poisoning . ,They are engaging in ... control of Campylobacter the commonest cause of infectious ... the Health Protection Agency. Campylobacters are found in poultry ...
... Alzheimers one more breakthrough has been achieved. Scientists in New ... of mice using a magnetic stimulus in the region ... at the American Academy for Neuroscience conference. If proven, the ... Alzheimers disease, if not a cure. ,Experts ...
... A new study has found that obese patients with asthma ... those who are not overweight . ,The study ... Fernando Holguin and colleagues at Emory University. ,As ... than 3,000 adults by examining a data from the four-state ...
Cached Medicine News:Health News:Combo Therapy may Be Highly Beneficial in Asthma Control 2Health News:Psychological Bullying Hits Just as Hard 2Health News:Experts to Develop New Weapons Against Food Poisoning 2Health News:Experts to Develop New Weapons Against Food Poisoning 3Health News:Magnets to the rescue of Alzheimers patients 2Health News:Obesity Might Lead to Severe Persistent Asthma Attacks: Study 2
... Detect™ IgM Capture ELISA is for the ... WNV recombinant antigens (WNRA) in serum as ... of West Nile virus infection in patients ... results must be confirmed by Plaque Reduction ...
Adult; dilates 6.0 to 34.0 French; individually packaged, sterile....
The removable inflation adapter allows the ureteroscope to be removed after the catheter is in place. Supplied sterile in peel-open packages. Intended for one-time use....
The removable inflation/injection adapter allows the cystoscope to be removed after the catheter is in place. Supplied sterile in peel-open packages. Intended for one-time use....
Medicine Products: